AGMB
AgomAb Therapeutics NV
8.70$
-22.1%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
AgomAb Therapeutics NV (AGMB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -12 million €. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q3 25 | Q4 25 | Q1 26 |
|---|---|---|---|---|
| -12 | -14 | -13 | -12 | |
| 0.1 | 0.1 | -0.1 | 0.1 | |
| 0.5 | 1.3 | 1.4 | 0.5 | |
| -1.6 | 0.1 | 1.4 | -1.6 | |
| 0.4 | 0.0 | 0.0 | 0.4 | |
| -0.4 | – | -30 | -0.4 | |
| -0.1 | -0.2 | 0.0 | – | |
| 82 | -0.2 | 0.0 | 82 | |
| 69 | -14 | -43 | 69 | |
| -13 | -14 | -13 | -13 |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.